Publication:
Cystic Fibrosis Patients Eligible for Modulator Drugs: Data From Cystic Fibrosis Registry of Turkey

dc.contributor.authorCobanoglu, Fatma Nazan
dc.contributor.authorErsoz, Deniz Dogru
dc.contributor.authorCakir, Erkan
dc.contributor.authorEyuboglu, Tugba Sismanlar
dc.contributor.authorPekcan, Sevgi
dc.contributor.authorCinel, Guzin
dc.contributor.authorBasaran, Abdurrahman Erdem
dc.contributor.authorIDAslan, Ayse Tana/0000-0002-5360-8517
dc.contributor.authorIDEyuboglu, Tugba Sismanlar/0000-0001-7284-4999
dc.date.accessioned2020-06-21T12:25:55Z
dc.date.available2020-06-21T12:25:55Z
dc.date.issued2019
dc.departmentOMÜen_US
dc.department-temp[Cobanoglu, Fatma Nazan] Ankara Univ, Fac Med, Dept Pediat Pulmonol, Ankara, Turkey -- [Ersoz, Deniz Dogru -- Yalcin, Ebru -- Kiper, Nural -- Emiralioglu, Nagehan] Hacettepe Univ, Fac Med, Dept Pediat Pulmonol, Ankara, Turkey -- [Cakir, Erkan -- Al Shadfan, Lina Muhammeden_US
dc.descriptionEuropean-Respiratory-Society (ERS) International Congress -- SEP 28-OCT 02, 2019 -- Madrid, SPAINen_US
dc.description.abstracten_US
dc.description.sponsorshipEuropean Respiratory Socen_US
dc.identifier.doi10.1183/13993003.congress-2019.PA4518
dc.identifier.issn0903-1936
dc.identifier.issn1399-3003
dc.identifier.urihttps://doi.org/10.1183/13993003.congress-2019.PA4518
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10595
dc.identifier.volume54en_US
dc.identifier.wosWOS:000507372406030
dc.language.isoenen_US
dc.publisherEuropean Respiratory Soc Journals Ltden_US
dc.relation.journalEuropean Respiratory Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCystic Fibrosis Patients Eligible for Modulator Drugs: Data From Cystic Fibrosis Registry of Turkeyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files